| CAPITAL GROUP JAPAN EQUITY FUND (LUX) ZH EUR | RVI JAPÓN | 22,11% | 80,06% | 91,30% | 231,92% |
| PICTET - BIOTECH HR EUR | RVI BIOTECNOLOGÍA | 22,11% | 84,39% | 27,58% | 79,56% |
| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) (CHF HEDGED) Q-DIST | RVI GLOBAL VALOR | 22,11% | 53,49% | 55,70% | 82,68% |
| FIDELITY FUNDS-UK SPECIAL SITUATIONS A-ACC-EUR | RVI UK VALOR | 22,10% | 82,25% | 69,78% | · |
| INVESCO NIPPON SMALL/MID CAP EQUITY C CAP JPY | RVI JAPÓN SMALL/MID CAP | 22,10% | 65,51% | 15,30% | 64,72% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND R USD HEDGED | RVI JAPÓN VALOR | 22,10% | 97,60% | 167,94% | 188,83% |
| SOLVENTIS AURA IBERIAN EQUITY, FI GD | RV ESPAÑA | 22,10% | 108,45% | · | · |
| BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME D2 USD | RVI GLOBAL | 22,09% | 59,52% | 66,90% | 155,49% |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 22,09% | 39,29% | -15,45% | · |
| SCHRODER ISF ASIAN OPPORTUNITIES I ACC USD | RVI ASIA EX-JAPÓN | 22,09% | 70,80% | 41,30% | 163,87% |
